Wilson病患者中的骨质疏松与骨密度:一项系统综述与Meta分析
该系统综述通过检索EMBASE和MEDLINE(建库至2017年4月),纳入4项研究共283例Wilson病患者,评估骨量减少和骨质疏松的发生率与风险。合并患病率分别为骨量减少36.5%(95%CI:14.8%-65.7%)和骨质疏松27.7%(95%CI:8.6%-60.9%);仅纳入成人时,骨量减少、骨质疏松和椎体骨折的患病率分别为50.0%(95%CI:42.0%-58.0%)、17.6%(95%CI:6.7%-38.6%)和8.01%(95%CI:4.05%-15.2%)。Meta回归显示年龄(负相关;P=0.002)和男性状态(正相关;P<0.001)对骨质疏松患病率有显著影响。
要点
- Wilson病患者中骨量减少合并患病率为36.5%(95%CI:14.8%-65.7%),骨质疏松为27.7%(95%CI:8.6%-60.9%)。
- 仅纳入成人时,骨量减少、骨质疏松和椎体骨折患病率分别为50.0%、17.6%和8.01%。
- 年龄(负相关;P=0.002)和男性状态(正相关;P<0.001)与骨质疏松患病率显著相关。
核心结论
- 作者认为Wilson病与骨量减少和/或骨质疏松可能存在关联。
- 年轻年龄和男性状态与Wilson病患者中较高的骨质疏松患病率相关。
研究设计与样本
- 系统综述与Meta分析,检索EMBASE和MEDLINE从建库至2017年4月。
- 纳入评估Wilson病患者骨量减少和/或骨质疏松发生或风险的研究。
- 共纳入4项研究、283例Wilson病患者;采用DerSimonian和Laird随机效应通用逆方差法合并效应估计。
主要发现
- Wilson病患者骨量减少合并患病率为36.5%(95%CI:14.8%-65.7%)。
- Wilson病患者骨质疏松合并患病率为27.7%(95%CI:8.6%-60.9%)。
- 仅纳入成人时,骨量减少、骨质疏松和椎体骨折的估计患病率分别为50.0%(95%CI:42.0%-58.0%)、17.6%(95%CI:6.7%-38.6%)和8.01%(95%CI:4.05%-15.2%)。
- Meta回归显示年龄(负相关;P=0.002)和男性状态(正相关;P<0.001)对骨质疏松患病率有显著影响。
- 关于Wilson病患者骨量减少和骨质疏松风险的数据有限。
临床怎么用
- 原文未据此给出推荐。
局限性
- 关于Wilson病患者骨量减少和骨质疏松风险的数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This systematic review aims to assess the occurrence and risks of osteopenia and osteoporosis in patientswith Wilson's disease (WD). A literature search was conducted utilizing EMBASE and MEDLINE frominception through April 2017. Studies assessing the occurrence or risk of osteopenia and/or osteoporosis inWD patients were included. Effect estimates from the individual study were extracted and combined usingrandom-effect, generic inverse variance method of DerSimonian and Laird. Of 754 studies, four studies with283 WD patients met the eligibility criteria and were included in the data analysis. The pooled prevalencerates of osteopenia and osteoporosis in WD patients were 36.5% (95% confidence interval [CI]: 14.8%-65.7%) and 27.7% (95%CI: 8.6%-60.9%), respectively. When meta-analysis was limited only to adults, the estimated prevalence rates of osteopenia, osteoporosis, and vertebral fracture were 50.0% (95%CI: 42.0%-58.0%), 17.6% (95%CI: 6.7%-38.6%) and 8.01% (95%CI: 4.05%-15.2%), respectively. Meta-regressionshowed significant impacts of age (negative correlation; P=0.002) and male status (positive correlation;P < 0.001) on the prevalence of osteoporosis. The data on risks of osteopenia and osteoporosis in WDpatients were limited. We suggests that there are potential associations of WD with osteopenia and/orosteoporosis. Also, young age and male status are correlated with the higher prevalence of osteoporosis inWD patients.
引用
- Chenbhanich J, Thongprayoon C, Atsawarungruangkit A, et al. Osteoporosis and bone mineral density in patients with Wilson's disease: a systematic review and meta-analysis. Osteoporos Int. 2017. PMID: 29110062. doi:10.1007/s00198-017-4295-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。